agilon health, inc.(AGL)— Stock Profile, AI Score & Financials

Healthcare · NYSE · AI-powered stock analysis, 32-signal quality score, SEC EDGAR financials, and institutional holdings. Updated 2026-06-30.

agilon health, inc. (AGL) stock profile, AI quality score, and SEC EDGAR financial data, a Healthcare sector company. 13F Pro's AI-powered ranking engine scores AGL at 44.9/100 on a 32-signal composite quality model, placing it at rank #1,894 of 2,961 stocks — the bottom half of the AI-ranked universe. AGL scores in the top quartile across institutional flow (93.1), revenue scale (80.2). Areas of concern include balance sheet strength (14.7) and free cash flow (24.3), which score below median versus the broader universe. Based on the latest XBRL financial filings (Q2 2026), agilon health, inc. reports quarterly revenue of $1.5B, net income of $18.0M, free cash flow of $-60.7M. Top institutional holders of AGL by reported 13-F value include Clayton, Dubilier & Rice, MORGAN STANLEY, North Peak Capital Management, based on the most recent SEC filings. AGL trades on the NYSE exchange and files with the SEC under CIK 1831097. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate AGL daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for agilon health, inc. directly from SEC EDGAR.